These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 23796974)

  • 1. What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
    Onal IK; Gokcan H; Benzer E; Bilir G; Oztas E
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):642-6. PubMed ID: 23796974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
    Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
    Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
    Sierra F; Forero JD; Rey M; Botero ML; Cárdenas A
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1165-71. PubMed ID: 23656465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
    Hosseini SM; Sharifipoor F; Nazemian F; Ghanei H; Zivarifar HR; Fakharian T
    Acta Med Iran; 2014; 52(4):271-4. PubMed ID: 24901856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
    Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
    Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
    Rakici H; Akdoğan RA; Bedir R; Copur A; Yilmaz A
    J Dig Dis; 2014 Sep; 15(9):508-13. PubMed ID: 24980811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study.
    Ergül B; Doğan Z; Sarikaya M; Filik L
    Helicobacter; 2013 Dec; 18(6):454-8. PubMed ID: 24011287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait.
    Alboraie M; Saad M; Al-Ali J; Malik M; Asem N; Schmidt I; Alfadhli AA
    Arab J Gastroenterol; 2015; 16(3-4):131-5. PubMed ID: 26611765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.